IMPACT OF ACUTE KIDNEY INJURY STAGING ON PROGNOSIS OF PATIENTS WITH CIRRHOSIS

• Published in: Arquivos de gastroenterologia
• Main Authors: SCHACHER, Fernando C, MATTOS, Angelo A, MULAZZANI, Carolina M, DETANICO, Rafaela B, FAVERO, Bruna, FONSECA, Bárbara B, FELIX, Patricia H, PASE, Tales Henrique S, KUPSKI, Carlos, MACHADO, Marta B, CORAL, Gabriela P, WILTGEN, Denusa, MATTOS, Angelo Z
• Format: Journal Article
• Language: Portuguese
• Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE 2020
• Subjects: GASTROENTEROLOGY & HEPATOLOGY; Prognosis; Prognóstico; Acute kidney injury, mortality; Cirrose hepática; Lesão renal aguda, mortalidade; Liver cirrhosis
• ISSN: 1678-4219
• DOI: 10.1590/s0004-2803.202000000-46

ABSTRACT BACKGROUND: Acute kidney injury (AKI) is a common and severe complication of cirrhosis. OBJECTIVE: To evaluate the impact of AKI staging on 30-day mortality of patients with cirrhosis. METHODS: We performed a retrospective cohort study of hospitalized patients with cirrhosis. Acute kidney injury (AKI) was diagnosed according to the International Club of Ascites recommendations and staged according to the European Association for the Study of the Liver guidelines. Comparisons between groups were made by one-way analysis of variance and Tukey test. Chi-square was calculated for dichotomous variables. Comparisons of renal impairment status among patients were performed using Kaplan-Meier statistics and differences between groups were analyzed using the log-rank test. A P-value <0.05 was considered to be statistically significant. RESULTS: Two hundred and thirty-two patients were included in the study. The diagnosis of AKI was performed in 98 (42.2%) of them. The overall 30-day mortality was 19.8% (46/232). Mortality increased as the degree of AKI progressed. Among patients who did not have AKI, mortality was 5.2% (7/134). When compared to patients without AKI, patients diagnosed with AKI stage 1a had mortality of 12.1% (4/33, P=0.152); patients with AKI stage 1b had mortality of 45% (18/40, P<0.001); and patients with AKI stages 2 or 3 had mortality of 68% (17/25, P<0.001). Moreover, it is noteworthy that full response to treatment was associated to a decreased mortality when compared to patients who did not show complete recovery of renal function (14.3% vs 57.9%, P<0.001). CONCLUSION: AKI stages 1b or greater, but not AKI stage 1a, are associated to higher 30-day mortality of patients with cirrhosis.